Nelson, Van Denburg & Campbell Wealth Management »

Sangamo Biosciences shares owned by Nelson, Van Denburg & Campbell Wealth Management

Quarter-by-quarter ownership of Sangamo Biosciences (SGMO) shares owned by Nelson, Van Denburg & Campbell Wealth Management from 13F filings

Historical chart of Nelson, Van Denburg & Campbell Wealth Management investment in Sangamo Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Sangamo Biosciences held by Nelson, Van Denburg & Campbell Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sangamo Biosciences by Nelson, Van Denburg & Campbell Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $338 507 0.67
2023-12-31 $254 471 0.54

More positions owned by Nelson, Van Denburg & Campbell Wealth Management

Ishares Core Dividend Growth Etf Etf (DGRO)
Vanguard Growth Etf Etf (VUG)
Vanguard Index Fds Mid-cap Value Index Viper Shs Etf Etf (VOE)
Vanguard Mid Cap Growth Etf Etf (VOT)
Ishares S&p 500 Index Etf (IVV)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Jpmorgan Active Value Etf Etf (JAVA)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Apple Stock (AAPL)
Vanguard S&p 500 Etf Etf (VOO)
Jpmorgan Active Growth Etf Etf (JGRO)
Spdr Ser Tr Dj Wilshire Small Cap Value Etf Etf (SLYV)
Microsoft Stock (MSFT)
Schwab Us Large Cap Growth Etf Etf (SCHG)
Ishares Morningstar Mid-cap Growth Etf Etf (IMCG)

View all positions for Nelson, Van Denburg & Campbell Wealth Management

Top funds holding Sangamo Biosciences

Daniel D. Thurber
Vanguard Group
D. E. Shaw & Co
Hudson Bay Capital Management
Two Sigma Investments
Two Sigma Advisers
Jpmorgan Chase & Co
Long Focus Capital Management
Citadel Advisors
Charles Schwab Investment Management
Millennium Management
Jacobs Levy Equity Management
HighTower Advisors
Dimensional Fund Advisors
Zacks Investment Management

View all funds holding Sangamo Biosciences